These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 18057435)
1. An update of treatment options for neovascular age-related macular degeneration. Iu LP; Kwok AK Hong Kong Med J; 2007 Dec; 13(6):460-70. PubMed ID: 18057435 [TBL] [Abstract][Full Text] [Related]
2. [The role of antiangiogenic agents in age related macular degeneration]. Tomi A Oftalmologia; 2010; 54(4):63-72. PubMed ID: 21516865 [TBL] [Abstract][Full Text] [Related]
3. [Comments on current therapeutic possibilities for neovascular age-related macula degeneration]. Klin Monbl Augenheilkd; 2006 Apr; 223(4):271-8. PubMed ID: 16639662 [TBL] [Abstract][Full Text] [Related]
5. Bevacizumab for the treatment of neovascular age-related macular degeneration. Pitlick JM; Vecera KF; Barnes KN; Reski JW; Forinash AB Ann Pharmacother; 2012 Feb; 46(2):290-6. PubMed ID: 22274144 [TBL] [Abstract][Full Text] [Related]
6. [The Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists--comments on the current therapy for neovascular AMD]. Pauleikhoff D; Bornfeld N; Gabel VP; Holz F; Roider H; ; ; Klin Monbl Augenheilkd; 2005 May; 222(5):381-8. PubMed ID: 15912454 [TBL] [Abstract][Full Text] [Related]
7. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Bottoni F; Massacesi A; Cigada M; Viola F; Musicco I; Staurenghi G Arch Ophthalmol; 2005 Dec; 123(12):1644-50. PubMed ID: 16344434 [TBL] [Abstract][Full Text] [Related]
8. A review of treatments for macular degeneration: a synopsis of currently approved treatments and ongoing clinical trials. Liu M; Regillo CD Curr Opin Ophthalmol; 2004 Jun; 15(3):221-6. PubMed ID: 15118509 [TBL] [Abstract][Full Text] [Related]